• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

基于肠道微生物的机器学习提高了 CRC 亚组的诊断效率。

Improved diagnostic efficiency of CRC subgroups revealed using machine learning based on intestinal microbes.

机构信息

School of Computer Science and Technology, Xi'an Jiaotong University, Xi'an, 710049, China.

Guangdong Hongyuan Pukang Medical Technology Co, Ltd, Guangzhou, 510000, China.

出版信息

BMC Gastroenterol. 2024 Sep 17;24(1):315. doi: 10.1186/s12876-024-03408-3.

DOI:10.1186/s12876-024-03408-3
PMID:39289618
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11409688/
Abstract

BACKGROUND

Colorectal cancer (CRC) is a common cancer that causes millions of deaths worldwide each year. At present, numerous studies have confirmed that intestinal microbes play a crucial role in the process of CRC. Additionally, studies have shown that CRC can be divided into several consensus molecular subtypes (CMS) based on tumor gene expression, and CRC microbiomes have been reported related to CMS. However, most previous studies on intestinal microbiome of CRC have only compared patients with healthy controls, without classifying of CRC patients based on intestinal microbial composition.

RESULTS

In this study, a CRC cohort including 339 CRC samples and 333 healthy controls was selected as the discovery set, and the CRC samples were divided into two subgroups (234 Subgroup1 and 105 Subgroup2) using PAM clustering algorithm based on the intestinal microbial composition. We found that not only the microbial diversity was significantly different (Shannon index, p-value < 0.05), but also 129 shared genera altered (p-value < 0.05) between the two CRC subgroups, including several marker genera in CRC, such as Fusobacterium and Bacteroides. A random forest algorithm was used to construct diagnostic models, which showed significantly higher efficiency when the CRC samples were divided into subgroups. Then an independent cohort including 187 CRC samples (divided into 153 Subgroup1 and 34 Subgroup2) and 123 healthy controls was chosen to validate the models, and confirmed the results.

CONCLUSIONS

These results indicate that the divided CRC subgroups can improve the efficiency of disease diagnosis, with various microbial composition in the subgroups.

摘要

背景

结直肠癌(CRC)是一种常见的癌症,每年在全球范围内导致数百万人死亡。目前,大量研究证实肠道微生物在 CRC 过程中发挥着关键作用。此外,研究表明,CRC 可以根据肿瘤基因表达分为几个共识分子亚型(CMS),并且已经报道 CRC 微生物组与 CMS 相关。然而,大多数先前关于 CRC 肠道微生物组的研究仅比较了患者与健康对照组,而没有根据肠道微生物组成对 CRC 患者进行分类。

结果

本研究选择了包括 339 例 CRC 样本和 333 例健康对照的 CRC 队列作为发现集,并使用 PAM 聚类算法基于肠道微生物组成将 CRC 样本分为两个亚组(234 个 Subgroup1 和 105 个 Subgroup2)。我们发现,不仅微生物多样性有显著差异(Shannon 指数,p 值 < 0.05),而且两个 CRC 亚组之间有 129 个共有属发生改变(p 值 < 0.05),包括 CRC 中的几个标志性属,如梭杆菌属和拟杆菌属。随机森林算法用于构建诊断模型,当将 CRC 样本分为亚组时,该模型显示出更高的效率。然后选择了一个包括 187 例 CRC 样本(分为 153 个 Subgroup1 和 34 个 Subgroup2)和 123 例健康对照的独立队列来验证模型,并确认了结果。

结论

这些结果表明,分组后的 CRC 亚组可以提高疾病诊断的效率,亚组中的微生物组成存在差异。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7717/11409688/76ce26f497ea/12876_2024_3408_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7717/11409688/11be36eb2a93/12876_2024_3408_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7717/11409688/857daa33a3d1/12876_2024_3408_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7717/11409688/307ac0728e27/12876_2024_3408_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7717/11409688/3854a6698ef6/12876_2024_3408_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7717/11409688/76ce26f497ea/12876_2024_3408_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7717/11409688/11be36eb2a93/12876_2024_3408_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7717/11409688/857daa33a3d1/12876_2024_3408_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7717/11409688/307ac0728e27/12876_2024_3408_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7717/11409688/3854a6698ef6/12876_2024_3408_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7717/11409688/76ce26f497ea/12876_2024_3408_Fig5_HTML.jpg

相似文献

1
Improved diagnostic efficiency of CRC subgroups revealed using machine learning based on intestinal microbes.基于肠道微生物的机器学习提高了 CRC 亚组的诊断效率。
BMC Gastroenterol. 2024 Sep 17;24(1):315. doi: 10.1186/s12876-024-03408-3.
2
The multispecies microbial cluster of Fusobacterium, Parvimonas, Bacteroides and Faecalibacterium as a precision biomarker for colorectal cancer diagnosis.具核梭杆菌、卟啉单胞菌、拟杆菌和粪杆菌的多物种微生物群作为结直肠癌诊断的精准生物标志物。
Mol Oncol. 2024 May;18(5):1093-1122. doi: 10.1002/1878-0261.13604. Epub 2024 Feb 17.
3
The Role of Fecal and as Early Diagnostic Markers of Colorectal Cancer.粪便 和 的作用:结直肠癌的早期诊断标志物。
Dis Markers. 2021 Nov 22;2021:1171239. doi: 10.1155/2021/1171239. eCollection 2021.
4
Leveraging sequence-based faecal microbial community survey data to identify a composite biomarker for colorectal cancer.利用基于序列的粪便微生物群落调查数据来识别结直肠癌的复合生物标志物。
Gut. 2018 May;67(5):882-891. doi: 10.1136/gutjnl-2016-313189. Epub 2017 Mar 24.
5
Using gut microbiota as a diagnostic tool for colorectal cancer: machine learning techniques reveal promising results.利用肠道微生物群作为结直肠癌的诊断工具:机器学习技术显示出有希望的结果。
J Med Microbiol. 2023 Jun;72(6). doi: 10.1099/jmm.0.001699.
6
Identification of intestinal microbiome associated with lymph-vascular invasion in colorectal cancer patients and predictive label construction.鉴定结直肠癌患者淋巴血管侵犯相关的肠道微生物组及构建预测标签。
Front Cell Infect Microbiol. 2023 May 12;13:1098310. doi: 10.3389/fcimb.2023.1098310. eCollection 2023.
7
Metagenomic analysis of faecal microbiome as a tool towards targeted non-invasive biomarkers for colorectal cancer.粪便微生物组宏基因组分析作为结直肠癌靶向非侵入性生物标志物的工具。
Gut. 2017 Jan;66(1):70-78. doi: 10.1136/gutjnl-2015-309800. Epub 2015 Sep 25.
8
Gut microbiota dysbiosis signature is associated with the colorectal carcinogenesis sequence and improves the diagnosis of colorectal lesions.肠道微生物失调特征与结直肠癌变序列相关,并能提高结直肠病变的诊断效能。
J Gastroenterol Hepatol. 2020 Dec;35(12):2109-2121. doi: 10.1111/jgh.15077. Epub 2020 Jun 22.
9
Potential of fecal microbiota for detection and postoperative surveillance of colorectal cancer.粪便微生物群在结直肠癌的检测和术后监测中的潜力。
BMC Microbiol. 2021 May 27;21(1):156. doi: 10.1186/s12866-021-02182-6.
10
Association Between Bacteremia From Specific Microbes and Subsequent Diagnosis of Colorectal Cancer.特定微生物引起的菌血症与随后结直肠癌诊断的相关性。
Gastroenterology. 2018 Aug;155(2):383-390.e8. doi: 10.1053/j.gastro.2018.04.028. Epub 2018 May 3.

引用本文的文献

1
Distinct microbes, metabolites, and the host genome define the multi-omics profiles in right-sided and left-sided colon cancer.不同的微生物、代谢物和宿主基因组决定了右半结肠癌和左半结肠癌的多组学特征。
Microbiome. 2024 Dec 28;12(1):274. doi: 10.1186/s40168-024-01987-7.

本文引用的文献

1
An independent evaluation in a CRC patient cohort of microbiome 16S rRNA sequence analysis methods: OTU clustering, DADA2, and Deblur.在结直肠癌患者队列中对微生物组16S rRNA序列分析方法进行的独立评估:OTU聚类、DADA2和Deblur。
Front Microbiol. 2023 Jul 25;14:1178744. doi: 10.3389/fmicb.2023.1178744. eCollection 2023.
2
Gut Bacteria and Its Related Metabolite Ptilosteroid A Could Predict Radiation-Induced Intestinal Injury.肠道细菌及其相关代谢产物豆甾醇 A 可预测放射性肠损伤。
Front Public Health. 2022 Mar 28;10:862598. doi: 10.3389/fpubh.2022.862598. eCollection 2022.
3
Metagenomics analysis reveals universal signatures of the intestinal microbiota in colorectal cancer, regardless of regional differences.
宏基因组分析揭示了结直肠癌中肠道微生物群的普遍特征,而与地域差异无关。
Braz J Med Biol Res. 2022 Mar 11;55:e11832. doi: 10.1590/1414-431X2022e11832. eCollection 2022.
4
Altered gut metabolites and microbiota interactions are implicated in colorectal carcinogenesis and can be non-invasive diagnostic biomarkers.肠道代谢物的改变和微生物群落的相互作用与结直肠癌的发生有关,并且可以作为非侵入性的诊断生物标志物。
Microbiome. 2022 Feb 21;10(1):35. doi: 10.1186/s40168-021-01208-5.
5
Performance determinants of unsupervised clustering methods for microbiome data.微生物组数据无监督聚类方法的性能决定因素。
Microbiome. 2022 Feb 5;10(1):25. doi: 10.1186/s40168-021-01199-3.
6
Strategies for the treatment of colorectal cancer caused by gut microbiota.肠道微生物群引起的结直肠癌的治疗策略。
Life Sci. 2022 Feb 1;290:120202. doi: 10.1016/j.lfs.2021.120202. Epub 2021 Dec 8.
7
Gut microbiome and its role in colorectal cancer.肠道微生物组及其在结直肠癌中的作用。
BMC Cancer. 2021 Dec 11;21(1):1325. doi: 10.1186/s12885-021-09054-2.
8
Dysbiosis of human gut microbiome in young-onset colorectal cancer.青年期结直肠癌患者的肠道微生物群失调。
Nat Commun. 2021 Nov 19;12(1):6757. doi: 10.1038/s41467-021-27112-y.
9
Multivariable association discovery in population-scale meta-omics studies.基于人群的宏基因组学研究中的多变量关联发现。
PLoS Comput Biol. 2021 Nov 16;17(11):e1009442. doi: 10.1371/journal.pcbi.1009442. eCollection 2021 Nov.
10
The Evolving Role of Consensus Molecular Subtypes: a Step Beyond Inpatient Selection for Treatment of Colorectal Cancer.共识分子亚型的演变角色:超越住院患者选择治疗结直肠癌的一步。
Curr Treat Options Oncol. 2021 Nov 6;22(12):113. doi: 10.1007/s11864-021-00913-5.